Last reviewed · How we verify

NCT04491656: WALANT

Evaluating Clinical Outcomes for Determining the Optimal Delay to Skin Incision Under WALANT

Completed NA Last updated 29 July 2020
What this trial tests

NA trial testing WALANT Technique in Hand Surgery in 34 participants. Completed in 15 July 2020.

Timeline
1 January 2019
Primary endpoint
15 July 2020
15 July 2020

Quick facts

Lead sponsorEast Avenue Medical Center, Philippines
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposeother
Enrollment34
Start date1 January 2019
Primary completion15 July 2020
Estimated completion15 July 2020
Sites1 location across Philippines

Drugs / interventions tested

Conditions studied

Sponsor

East Avenue Medical Center, Philippines

Who can join

Eligibility, any sex, with Hand Surgery or Orthopedic Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Further studies are needed to establish the effects of WALANT in performing most common hand surgeries, in relation to its clinical outcomes and intraoperative blood loss. Therefore, this study aims to identify the best interval time to perform elective hand surgeries using WALANT technique, document clinical outcomes and identify potential complications

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of WALANT Technique

Trials testing the same drug.

Other recruiting trials for Hand Surgery

Currently open trials in the same condition.

Other East Avenue Medical Center, Philippines trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04491656.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing